April 29 (Reuters) - Neogenomics Inc NEO.O:
NEOGENOMICS Q1 REVENUE USD 168 MILLION VERSUS. IBES ESTIMATE USD 171 MILLION
NEOGENOMICS Q1 NET INCOME USD -26 MILLION
NEOGENOMICS Q1 ADJUSTED EBITDA USD 7 MILLION VERSUS. IBES ESTIMATE USD 5.67 MILLION
NEOGENOMICS Q1 GROSS PROFIT USD 73 MILLION
NEOGENOMICS Q1 OPERATING EXPENSES USD 101 MILLION
NEOGENOMICS Q1 ADJUSTED NET INCOME USD -500 THOUSAND VERSUS. IBES ESTIMATE USD -1.4 MILLION
Source text: ID:nBw43w7Mxa
Further company coverage: NEO.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.